PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Atea Pharmaceuticals, Inc., Boston, Massachusetts, USA good.steven@ateapharma.com.\', \'Department of Animal, Dairy & Veterinary Sciences, Utah State University, Logan, Utah, USA.\', \'Atea Pharmaceuticals, Inc., Boston, Massachusetts, USA.\', \'UniversitĂ  degli Studi di Cagliari, Monserrato, Italy.\', \'Architecture et Fonction des MacromolĂ©cules Biologiques, Marseille, France.\']
?:citedBy
  • -1
?:creator
?:doi
  • e02479-2010.1128/AAC.02479-20
?:doi
?:hasPublicationType
?:journal
  • Antimicrobial agents and chemotherapy
is ?:pmid of
?:pmid
?:pmid
  • 33558299
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.291
?:rankingScore_hIndex
  • 226
is ?:relation_isRelatedTo_publication of
?:title
  • AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2 In Vitro and a Promising Oral Antiviral for Treatment of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33558299>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33558299>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all